1. Introduction
Delivery of a functional DNA to mammalian cells is an attractive approach for genetic manipulation of the cells in biomedical research as well as in gene therapy for treating critical human diseases. Following delivery to the cytoplasm, a foreign gene enters the nucleus and is transcribed to the corresponding mRNA, which is subsequently transported to the cytoplasm for translation into a specific protein. However, a gene-silencing element, such as an antisense onligonucleotide or a small interfering RNA blocks the transcription of a target mRNA. Thus, nucleic acid delivery has been an essential tool either to turn on or off the expression of a particular gene in basic research laboratories.
Intensive research in the last three decades led to the development of a number of viral and non-viral vectors. However, an ideal vector in terms of safety and efficacy is still lacking. Synthetic non-viral vectors, such as cationic polymers, lipids and peptides, are relatively safe, but extremely inefficient. On the other hand, viral systems are by far the most effective means of DNA delivery to mammalian cells, but some major limitations including toxicity, immunogenicity, restricted targeting of specific cell types, restricted DNA carrying capacity, production and packaging problems, recombination and high cost, limit their successful applications in basic research and clinical medicine. The effectiveness of a viral particle is the result of its highly evolved and specialized structure basically composed of a protein coat surrounding a nucleic acid core. Such a highly organized structure can prevent viral particles from unwanted interactions with serum components, while promoting subsequent internalization by cells, escape from endosomes, and release of genetic material from the particle either before or after entering the nucleus. Development of a non-viral approach having the beneficial virus-like properties and lacking the disadvantageous aspects would emerge as the most attractive one for implementation in research laboratories and gene therapy.
A major barrier to the non-viral delivery is low uptake of DNA across the plasma membrane of a cell owing to the inappropriate and ineffective interactions of the DNA delivery vehicle with the cell membrane. Negatively charged DNA molecules are usually condensed with cationic reagents to allow formation of the complexes carrying net positive charges. The resulting complexes can interact electrostatically with anionic heparan sulfate proteoglycans (syndecans) on cell surface and reach the cytoplasmic side in the form of endosomes through endocytosis [1]. The extremely low pH and enzymes within the late endosomes usually bring about degradation of entrapped DNA and associated complexes. Finally, DNA that survives both endocytic processing and cytoplasmic nucleases must dissociate from the condensed complexes either before or after nuclear translocation through nuclear pore or during cell division.
Many therapeutic applications demand a vehicle with capability of delivering transgene(s) to a selective cell type in order to increase the expression efficacy and alleviate any side effect. A common strategy in non-viral case involves attachment of a targeting moiety onto a polycation (lipid or polymer) backbone which finally condenses the DNA through ionic interactions. Targeting moiety can enable the resulting DNA carrier to bind to a receptor, lectin, antigen or cell-adhesion molecule on plasma membrane prior to internalization via endocytosis or phagocytosis. Polylysine, the first backbone used for gene delivery has been conjugated to a diverse set of cell-specific ligands, such as asialoorosomucoid [2], transferrin [3], epidermal growth factor (EGF) [4], mannose [5], fibroblast growth factor (FGF) [6] and antibodies [7] for targeting, respectively, hepatocytes via asialoglycoprotein receptors, transferrin receptor-positive cells, EGF receptor-carrying cells, macrophages through membrane lectins, FGF receptor-bearing cells and lymphocytes via surface-bound antigens. In the similar fashions, polymers like polyethylenimine and liposomes have been coupled to other cell surface receptor-specific ligands in addition to those described above, such as integrin-binding peptide conjugated onto PEI to target integrins on cell surfaces [8] and vitamin folate conjugated onto liposomes through a polyethylene spacer to target folate receptor-bearing cells [9].
Cell adhesion molecules (integrin, syndecan, cadherin, selectin) which are a diverse group of cell surface proteins mediating interactions between cells, and between cells and the extracellular matrix, are valuable targets for precise gene delivery to haematopoietic cells, airway epithelial cells, tumor cells and vascular endothelial cells using synthetically designed non-viral vectors [10].
Recently, we have reported on the development of a safe, efficient nano-carrier system of carbonate apatite which can assist both intracellular delivery and release of DNA leading to very high level of trans-gene expression in cancer and primary cells [11-13]. We have also revealed a new approach of organic-inorganic hybrid carrier devised by complexing fibronectin and E-cadherin-Fc chimera electrostatically with nano-particles of carbonate apatite [14, 15]. Specific recognition to cell surface integrin and E-cadherin molecules through double ligand-coated nano-particles, resulted in synergistic acceleration of transgene delivery and consequential expression into embryonic stem cells. Instead of simultaneous mixing of DNA and cell-adhesive molecules in particle-preparation medium and subsequent incubation, step-wise addition and incubation of DNA and the protein molecules, results in improved DNA loading and decreased particle diameter with ability of recognizing stem cell surface for more efficient transgene delivery. Activation of PKC which might up-regulate both integrin and E-cadherin, enhances transgene expression in mouse embryonic carcinoma cells.
2. Materials and Methods
2.1. Reagents
Plasmids, pGL3 (Promega) containing a luciferase gene under SV40 promoter and pEGFP-N2 (CLONTECH Laboratories, Inc.) having a green fluorescence protein gene under CMV promoter were propagated in the bacterial strain XL-1 Blue and purified by QIAGEN plasmid kits. Lipofectamine 2000 and DMEM were purchased from Invitrogen and Gibco BRL, respectively. Fibronectin was bought from Sigma and expression as well as purification of E-cad-Fc fusion proteins was done according to the previously described report [16].
2.2. Cell Culture
HeLa cells were cultured in 75-cm2 flasks in Dulbecco’s modified Eagle’s medium (DMEM, Gibco BRL) supplemented with 10% fetal bovine serum (FBS), 50 μg penicillin ml-1, 50μg streptomycin ml-1 and 100μg neomycin ml-1 at 37°C in a humidified 5% CO2-containing atmosphere. F9, a mouse teratocarcinoma stem cell line and EB3, a mouse embryonic stem cell line were cultured in gelatin-coated 25-cm2 flasks. F9 cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM, Gibco BRL) supplemented with 10% fetal bovine serum (FBS) at 37°C in a humidified 5% CO2-containing atmosphere. Feeder-free murine ES cells were maintained in KNOCKOUT-DMEM (Invitrogen), supplemented with 1 mM L-glutamine, 1% nonessential amino acids (Invitrogen), 0.1 mM β-mercaptoethanol (Sigma Chemical), 10% FBS and 1,000 units/ml leukemia inhibitory factor (LIF) (Chemicon). All media contained 50 μg/ml penicillin, 50 μg/ml streptomycin, and 100 μg/ml neomycin.
2.3. Transfection of cells
Cells from the exponentially growth phase were seeded at 50,000 cells per well into 24-well plates the day before transfection. 3 to 6 μl of 1 M CaCl2 was mixed with 2 μg of plasmid DNA in 1 ml of fresh serum-free HCO3- - buffered (pH 7.5) medium (DMEM) and incubated for 30 min at 370c for complete generation of DNA/carbonate apatite particles. For generation of ECM protein-embedded carbonate apatite particles, fibronectin and E-cad-Fc proteins were added either alone or together to a final concentration of 5 μg/ml, to Ca2+ and DNA-containing DMEM followed by incubation at 370c for 30 min. Medium with generated ECM protein-associated or non-associated, DNA-containing particles was added with 10% FBS to the rinsed cells. After 4 hr incubation, the medium was replaced with serum supplemented medium and the cells were cultured for 1 day. Luciferase gene expression was monitored by using a commercial kit (Promega) and photon counting (TD-20/20 Luminometer, USA). Each transfection experiment was done in triplicate and transfection efficiency was expressed as mean light units per mg of cell protein. For lipofectamine-mediated transfection, protocol provided by Invitrogen was followed in a 24-well plate. Cells were incubated with DNA/lipofactamine complexes in serum-free media for 4 hr and like above, grown for 1 day after replacement with fresh serum media.
For transfection with calcium phosphate-DNA co-precipitation, briefly, 12 μg of plasmid DNA was added to 300 μl of a solution containing 250 mM CaCl2. This solution was added to 300μl of a 2×HBS (50 mM Hepes, 140 mM NaCl, 1.5 mM Na2HPO4.2H2O, pH 7.05) and mixed rapidly by gentle pipetting twice. The DNA/CaPi mixture was incubated at room temperature for the period of time indicated. After addition of 100 μl of the incubated mixture drop-wise to 1 ml serum supplemented media of each well, cells were incubated for 4 hr and like above, after replacement with fresh serum media, grown for 1 day.
2.4. MTT assay
HeLa cells were transfected and cultured for 1 day as described above. 30 μl of MTT solution (5mg/ml) was added to each well and incubated for 4 hrs. 0.5 ml of DMSO was added after removal of media. After dissolving crystals and incubating for 5 min at 370C, absorbance was measured in a microplate reader at 570 nm with a reference wavelength of 630 nm.
2.5. Chemical analysis
Following generation of carbonate apatite as described above, using 6 mM Ca2+ and no DNA, precipitated particles were lyophilized after centrifugation and washing with distilled deionized water. Other apatite particles generated as described above, were also similarly lyphilized. Calcium and phosphorus contents were determined using SPS 1500 VR Atomic Absorption Spectrophotometer. Carbon and fluorine were estimated by CHNS-932 (Leco, USA) and SX-elements micro analyser, YS-10 (Yanaco, Japan), respectively.
2.6. Infrared spectroscopy
Fourier transform-infrared spectroscopy of apatite particles prepared as described above, was performed using FT/IR-230, JASCO. The samples were ground in a mortar and approximately 1 mg was thoroughly mixed with 300 mg of ground spectroscopic grade KBr. Transparent pellets were prepared in a KBr die with an applied load of 8000 kg, under a vacuum of 0.5 torr.
2.7. X-ray diffraction
The x-ray diffraction powder reflections of the particles prepared as described above, were recorded using M18XHF-SRA diffractometer system.
2.8. Particle size measurements
For visualization by a scanning electron microscope (SEM), a drop of DNA-carbonate apatite suspension prepared according to the instructions in transfection protocol, was added to a carbon-coated SEM stage and dried, followed by observation by a high resolution SEM (S-800, Hitachi, Japan). Dynamic light scattering (DLS) measurement for particle suspension was carried out with a Super-dynamic Light Scattering Spectrophotometer, ‘Photal’ (Otsuka Electronics) at 75 mW Ar laser.
2.9. Confocal laser scanning microscopy
pGL3 vector was labeled with PI at a PI/DNA ratio of 1:1 and particles generated with this labeled plasmid (described in transfection protocol), were incubated with HeLa cells for 6 hours. Acidic compartments were labeled with 5μM LysoSensor, according to the instructions provided by Molecular Probes, and membrane-bound precipitates were removed by 5 mM EDTA in PBS before observation by LEICA TCS-NT.
2.10. SDS-PAGE and Western blotting
Following generation of carbonate apatite as described above using 3 mM Ca2+ and required amount of fibronectin or E-cad-Fc chimera and no DNA and centrifugation at 15000 rpm for 5 min at 40C, precipitated particles were washed with water with several centrifugation steps to remove unbound proteins and dissolved with 50 mM EDTA in PBS for subsequent analysis by 7.5% SDS-PAGE in reducing condition. In order to see particle-bound fibronectin, after SDS-PAGE, the gel was stained with Coumassie blue, washed and dried. For detection of particle-associated E-cad-Fc, proteins after being run by SDS-PAGE were transferred to PVDF membrane (Immobilon, Millipore) and 80 mA current was applied for 90 min to complete transfer of the proteins. The PVDF membrane was washed with PBS (-)-containing 0.1% Tween 20 and then blocked for 1 hr at room temperature by “Blocking One” (Nacalai Tesque, Japan). The membrane was incubated with horseradish peroxidase (HRP)-conjugated anti-mouse IgG for 1 hr and washed with PBS-T three to four times to completely remove non-specific interactions. Enhanced chemiluminescence system (Amersham Bioscience) was used for visualization.
2.11. DNA labelling, fluorescence microscopy and flow cytometry
Plasmid DNA was labelled non-covalently with propidium iodide (PI) using 1:1 weight ratio of DNA to PI in the particle preparation medium. Labelled DNA inside the cells was observed by a fluorescence microscope (Olympus-IX71), following 4 hr incubation of differentially formulated particle suspensions with F9 cells and removing extracellularly bound particles by 5 mM EDTA in PBS. For flow cytometric analysis using FACS Calibur (Becton, Dickinson and Company), 1 day after transfection with pEGFP plasmid DNA, F9 cells were collected in a sorter buffer following treatment with trypsin-EDTA and repeated centrifugation and washing of the resulting cell pellet with PBS (-) (2 times).
3. Results and Discussion
3.1. Generation of carbonate apatite particles
Addition of only 3 mM Ca2+ to the HCO3 - - buffered cell culture medium (DMEM or Willium E, pH 7.5) and incubation at 370C for 30 min, resulted in microscopically visible particles. Generation of these particles only in HCO3 - -, but not in Hepes-buffered media or solution (pH 7.5) containing the same amount of exogenous Ca2+ and phosphate (0.9 mM), indicates the possible involvement of carbonate along with phosphate and Ca2+ in particle formation. Elemental analysis proved the existence of C (3%), P (17%) and Ca2+ (32%) and FT-IR spectra (Fig. 1a) identified carbonate, as evident from the peaks between 1410 and 1540 cm-1 and at approximately 880 cm-1, along with phosphate in the particles, as shown by the peaks at 1000-1100 cm-1 and 550-650 cm-1. X-ray diffraction patterns (Fig. 1b) indicated less crystalline nature, represented by broad diffraction peaks of the particles, compared to that of hydroxyaptite (Fig. 1c) – an intrinsic property of carbonate apatite [12].
3.2. Influences of pH and temperature on generation of effective particles of carbonate apatite
We have investigated a long range of pH (7.0 to 7.9) of the HCO3 − –buffered medium as well as incubation temperatures (25 °C to 65 °C) in order to make particles by exogenously added Ca2+ and subsequently transfect HeLa cells using the generated particles. Interestingly, the optimal Ca2+ concentrations required for generation of effective number of DNA/carbonate apatite particles leading to the high transfection efficiency, were inversely related to the pHs of the media (Fig. 2-a) and the incubation temperatures (Fig. 2-b). Thus, while 4 mM Ca2+ was sufficient to induce particle formation at pH 7.4 by incubating the Ca2+-supplemented buffered medium for 30 min at 37 °C, only 1 mM2+ was enough to stimulate particle generation to the similar level at pH 7.9. Like pH, incubation temperatures have also profound and sensitive effects on particle formulation and subsequent trans-gene delivery. Thus, at the incubation temperature of 37 °C, 3 mM Ca2+ was able to induce the proper “supersaturation” whereas at 65 °C, only 1 mM Ca2+could stimulate “supersaturation” development to a similar extent – a prior need for generation of the particles. The decline below the high efficiency level of transfection was due to the formation of too few particles (microscopically observed) since increase in pH or temperature contributed to the development of “supersaturation” by increasing the ionization of phosphate and carbonate in the solution. The new system of particle synthesis is, therefore, very flexible since it allows us to make particles at a wide range of pH and temperatures. The analysis also indicates that induction of “supersaturation” as required for particle formation, can be delicately controlled by manipulating the parameters.
3.3. Tranfection efficiency and cell viability assessment
To evaluate the role of carbonate apatite as a powerful carrier of genetic material, we compared transfection efficiency of different techniques including two frequently used ones- CaP co-precipitation method and lipofection. In HeLa cell, for example, luciferase expression level for carbonate apatite-mediated transfection was over 25-fold higher than for lipofection and CaP co-precipitation method (Fig. 2c). Nano gram level of DNA was even sufficient for efficient transgene expression (Fig. 2c). Transfection efficiency was also significantly high in HepG2 (Fig. 2d), NIH 3T3 cells (Fig. 2e) and mouse primary hepatocytes (Fig. 2f). We performed MTT assay in HeLa cells (not shown here) to clarify that high transfection efficiency was accompanied by high viability of the cells [12].
3.4. Estimation of particle sizes and cellular uptake of particle-associated plasmid DNA
To explore why carbonate apatite is so efficient as a vector for gene delivery, we investigated two basic properties of carbonate apatite [12]. Carbonate, when present in the apatite structure, limits the size of the growing apatite crystals and increases the dissolution rate [12]. We carried out scanning electron microscopic observation of generated carbonate apatite (Fig. 3A) which revealed reduced growth of the crystals, most of which had diameters of 50 to 300 nm. We verified this size limiting effect of carbonate by observing cellular uptake of the PI (propidium iodide)-labeled plasmid DNA adsorbed to the apatites, since large particles are phagocytosed less efficiently than small ones [12]. DNA was carried into the cells by carbonate apatite (Fig. 3B-c) at least 10 times more efficiently than hydroxyapatite, generated by 1 min incubation (Fig. 3B-d). Longer period (30 min) incubation resulted in large hydroxyapatite particles [12], showing significantly reduced transfection efficiency [12] (Fig. 2A) due to extremely low cellular uptake of DNA [12]. Our findings, therefore, clearly suggest that carbonate apatite is superior over hydroxyapatite for its intrinsic property of preventing crystal growth, leading to high efficiency cellular uptake of DNA.
3.5. Endosomal escape of plasmid DNA carried by nanoparticles
To evaluate the role of endosomal escape of DNA in transgene expression, following endocytosis of PI-labeled plasmid DNA, we labeled endosomes with LysoSensor (a fluorescence probe for endosomes). Following 6 hr of DNA uptake by cells, a significant portion of DNA (red colour) appeared to be released from endosomes (green colour) after colocalization of plasmid DNA with endosomes (Fig. 4).
3.6. Relationship of endosomal pH and crystalline properties of particles affecting transfection
Treatment with bafilomycin A1, a specific inhibitor of v-ATPase (a proton pump for acidification of endocytic vesicles) resulted in drastic reduction of transfection efficiency in HeLa cells (Fig. 5A), which indicated that acidic environment might be necessary for solubilization of carbonate apatite to release DNA from the apatite. To establish this notion, we generated fluoridated carbonate apatite to see the effect of solubility of the particles on transfection efficiency, since incorporation of fluoride reduces the solubility of the apatite [12]. Surprisingly, transfection efficiency was reduced gradually to a significant extent (100 fold) with increasing fluoride level in carbonate apatite (Fig. 5B).
To establish a relationship between transfection efficiency and dissolution rates of the apatites, turbidity (320 nm) measurement was done as an indicator of their solubilization, following an acid load in solution of generated apatites. Carbonate apatite generated in presence of increasing concentrations of NaF, showed gradual decrease in dissolution rates, as evident from changes in turbidity, following adjustment of pH from 7.5 to 7.0 with 1 N HCl (Fig. 6 A, B), which is consistent with gradually reduced transfection efficiency of fluoridated carbonate apatites (Fig. 5 B). With decreasing pH from 7.0 to 6.8, carbonate apatite was completely solubilized within 1 min, whereas fluoridated carbonate apatite was partially dissolved (Fig. 6 B).
To examine whether dissolution rates of apatites are correlated with their degree of crystallization, we studied x-ray diffraction of the apatites (Fig. 7), which clearly indicates that apatite with higher degree of crystallization, had lower solubility (Fig. 6A). In other words, apatites with higher crystallinity (Fig. 7) showed lower transfection efficiency (Fig. 5 B). The gradual increase in crystallinity owing to increased level of incorporated fluoride in carbonate apatite (Fig. 7) resulted in gradual decrease in transfection efficiency (Fig. 5B).
To establish that decreased transfection efficiency was only due to decreased solubility of fluoridated carbonate apatite, but not by any other fluoride-mediated effects, we examined the effects of strontium which, when incorporated into carbonate apatite, is known to improve the crystallinity and reduce the solubility of the apatite, but to a lesser extent than fluoride [12]. As expected, addition of strontium chloride during preparation of carbonate apatite reduced its dissolution rate but to a level less than that observed for fluoride (Fig 6B). Moreover, transfection efficiency was gradually decreased with increasing concentrations of strontium chloride during generation of DNA/carbonate apatite particles (Fig. 5B). Taken together, our findings suggest that intracellular release of DNA through dissolution of apatite should play a major role in carbonate apatite-mediated transfection.
3.7. Immobilization of cell-adhesive molecules on nano-particle surface
Since embryonic stem cells produce substantial amount of fibronectin-specific integrins as well as E-cadherin as transmembrane proteins [17], we hypothesized that if the nano-particles of carbonate apatite could be complexed with fibronectin and E-cadherin, either individually or together, they might recognize in the immobilized state the corresponding receptors on cell surface in order to facilitate quick internalization of the composite particles across the plasma membrane through endocytosis. These nano-apatite particles possess anion- and cation-binding domains which enable them to bind to both acidic and basic amino acids of protein molecules [18, 19]. On the other hand, fibronectin as well as E-cadherin are rich in acidic amino acid residues [19, 20] which make them excellent candidates for possible binding with the apatite particles. We have examined whether these “cell adhesive molecules” could, in deed, bind to the particles, by SDS-PAGE and Western blot analysis, following generation of apatite-protein composites and decomplexation through EDTA-mediated particle dissolution. Whereas binding affinity of the particles for fibronectin was relatively lower requiring higher amount of initially added fibronectin as observed by SDS-PAGE, almost all E-cad-Fc was found to be associated with the particles as verified by Western blot analysis (Fig 8). Very high affinity for E-cadherin could be interpreted by the previous report that E-cadhein has many exposed acidic residues in several loop structures responsible for binding divalent cation Ca2+ [20].
3.8. Enhanced cellular uptake of DNA by immobilized cell-adhesive molecules
In order to explore whether apatite particles functionalized with fibronectin and E-cad-Fc can facilitate enhanced delivery of apatite-associated plasmid DNA across the plasma membrane, we examined cellular uptake of the DNA labeled with propidium iodide (PI) [19], following 4 hr incubation of F9 cells with various particle formulations. As shown in Fig. 9, while with only apatite particles, delivery of PI-labeled DNA into the cells was extremely low, complexation of the particles with either fibronectin or E-cad-Fc resulted in significantly improved DNA delivery, suggesting that immobilized fibonectin or E-cad-Fc retained their functionalities in order to recognize specific cell surface integrin or E-cadherin, respectively for enabling subsequent internalization of the whole particle composite through endocytosis [19, 21]. Moreover, the apatite particles when complexed with both fibronectin and E-cad-Fc, demonstrated more pronounced DNA delivering activity compared to the particles embedded with either fibronectin or E-cad-Fc, indicating a synergistic effect of the multifunctional particles on endocytosis through simultaneous recognition of extracellular domains of specific integrin as well as E-cadherin molecules.
3.9. Quantitation and validation of trans-gene expression facilitated by cell-adhesive molecules
Since expression of a trans-gene is the result of overcoming a number of barriers including entry into the cells, release from the particle and endosomes and finally nuclear translocation [17, 18], we have investigated whether improved DNA delivery as a result of integrin- and E-cadherin-mediated endocytosis of composite particles (Fig. 9) contributed to the similar extent to final protein expression. Quantitative luciferase expression analysis indicated that particles complexed with fibronectin or E-cad-Fc promoted trans-gene expression with a value which was almost 20 times higher than that achieved for the particles only (Fig 10). A prior optimization study demonstrated that 1 to 5 μg/ml of fibronectin as well as E-cad-Fc conferred the best transfection efficiency and was, therefore, maintained for all subsequent experiments. Finally, synergistic activity of fibronectin and E-cad-Fc which caused huge cellular uptake of DNA (Fig. 9), further accelerated gene expression efficiency with a value almost 3 times higher than that observed for commercially available lipofectamine (Fig. 10). With increasing the total amount of initially added DNA up to 4 μg, a further increase in trasfection efficiency was observed (data not shown here) possibly due to the higher loading of DNA into the crystals with the consequence of more DNA getting inside the cells. The high level of expression could directly be observed by fluorescence microscopy which demonstrated many GFP-expressing F9 cells (Fig. 11). Fluorescence Activated Cell Sorting (FACS) analysis demonstrated that almost 60% cells were GFP-positive following transfection with the particles carrying, in addition to pEGFP plasmid DNA, both fibronectin and E-cad-Fc (Fig 11). MTT assay was performed in F9 cells to clarify that high transfection efficiency was not accompanied by significant toxicity of the cells (data not shown here). In order to establish that such organic-inorganic hybrid particles promote trans-gene delivery and expression through specific interactions with cell-surface molecules (integrin or E-cadherin), we added increasingly high amounts of free fibronectin to the preformed particle suspension carrying both fibronectin and E-cadherin and incubated with the cells for the same period of time (4 hr) as followed in usual transfection procedure. Transfection efficiency decreased as the concentration of free fibronectin increased from 5 to 100μg/ml, indicating the involvement of specific interactions between immobilized fibronectin and the corresponding specific integrin receptors (Fig 12). At a sufficiently high concentration (300 μg/ml), free fibronectin drastically reduced luciferase expression suggesting that high amount of fibronectin molecules not only saturate their specific integrins and block binding of immobilized fibronectin needed for particle internalization, but also shield cell-surface E-cadherin and prevent specific binding of particle surface-embedded E-cad-Fc chimera leading to very low cellular uptake of particle-associated DNA and diminished luciferase expression. Since embryonic stem cells are the final target for genetic modification in regenerative medicine, we applied the new transfection approach to mouse embryonic stem cells. As shown in Fig. 13, only apatite particles were extremely inefficient in transfecting the cells, whereas fibronectin-bound particles to some extent promoted GFP expression and fibronectin and E-cad-Fc-bound particles to a significant extent accelerated trans-gene expression, thus proposing that the synergistic effect is a universal way of accelerating trans-gene delivery and expression using inorganic nano-particle-associated cell recognizable proteins. Quantitative luciferase expression in embryonic stem cells indicated that particles complexed with fibronectin and E-cad-Fc individually, promoted trans-gene expression with efficiency approximately 9 and 7 times higher, respectively, than that achieved with the particles only (Fig. 14). However, when the particles were associated with both fibronectin and E-cadherin-Fc, a synergistic effect resulted in remarkable level of transgene expression leading to almost 40 and 28 times higher efficiency than that obtained by apatite particles and widely used lipofectamine 2000 system [14].
3.10. DNA binding with differentially formulated cell adhesive protein-embedded particles
Since direct mixing of DNA and cell-adhesive proteins in Ca2+ and PO4 3--containing medium prior to induction of particle formation by incubation at 370C for 30 min, could interfere with maximum DNA loading due to the competitive binding of the proteins to the growing crystals, we investigated DNA binding efficiency by first adding DNA to the particle-preparation medium prior to time-dependent addition of the proteins [22]. As shown in Fig. 15, in the direct mixing process (control), DNA binding is much higher for E-cadherin-Fc compared to fibronectin, indicating that E-cadherin-Fc facilitates DNA loading probably by accelerating particle growth because turbidity of particle suspension was higher for E-cadherin-Fc than for fibronectin (not shown). It is worth mentioning that only particles have also higher affinity towards DNA (almost 40%) that the particles associated with fibronectin which showed lower turbidity than the particles (mentioned before), suggesting again that particle growth has a significant role in the observed DNA binding efficiency. When cell adhesive proteins were added after 5, 10 and 20 min from the start of incubation of DNA-containing particle- preparation medium, followed by incubation for an additional 25, 20 and 10 min respectively, DNA binding to the particles was enhanced to a significant extent for fibronectin, E-cadherin and fibronectin/E-cadherin-Fc compared to the control, suggesting than a competitive inhibition of DNA binding happens in the direct mixing procedure while delaying addition of the proteins to the growing crystals and DNA favors optimal DNA binding to the particles. Decreased DNA binding to the particles with which E-cadherin and fibronectin/E-cadherin-Fc were incubated for only 1 min, could be due to the reduced growth of the particles for too long time absence of E-cadherin-Fc in particle-preparation medium.
3.11. Size determination for differentially formulated cell adhesive protein-embedded particles
Particle growth kinetics is correlated to the size of the finally formed particles and excessive growth lead to big size particles being inefficient for intracellular DNA delivery [11]. Since E-cadherin-Fc favors particle growth by making bridges among the neighboring E-cadherin-anchored crystals [14], prolonged incubation together with DNA for generation of functional particles might lead to large complex particles. As shown in Fig. 16, fibronectin association maintained the average particle diameter close to 300 nm whereas E-cadherin-Fc or fibronectin/E-cadherin-Fc induced the particle growth with an average diameter of approximately 900 nm. However, addition of E-cadherin-Fc or fibronectin/E-cadherin-F after 5, 10, 20 and 29 min from the start of incubation of DNA-containing particle-preparation medium, followed by incubation for an additional 25, 20, 10 and 1 min respectively, resulted in the particles of decreasing sizes with a minimum average value of approximately 300 nm. On the other hand, time-dependent association of fibronectin having no role in particle growth induction, demonstrated no significant change in overall particle diameter, suggesting that particle growth is the size-determining factor for cell-adhesive protein-embedded particles.
3.12. Cellular delivery of DNA in association with cell adhesive protein-embedded particles
Both DNA binding to the particles and particle size contribute to the overall uptake of DNA by cells. As shown in Fig. 17, only particles were very inefficient in delivering propidium (PI)-labeled plasmid DNA into F9 cells whereas particles being associated with fibronectin or E-cadherin-Fc significantly increased cellular delivery of labeled DNA in a 4 hr uptake study. Moreover, particles when complexed with both fibronectin and E-cadherin-Fc in direct mixing with DNA, synergistically accelerated delivery of PI-labeled DNA into the cells. Particles prepared by addition of fibronectin or fibronectin/E-cadherin-Fc after 5, 10 and 20 min from the start of incubation of labeled DNA-containing particle preparation medium and incubation for an additional 25, 20 and 10 min respectively, mediated increased cellular delivery of labeled DNA, indicating that transgene delivery is well-controlled by the sizes as well as the DNA-loading efficiency of cell adhesive protein-embedded particles. Reduced DNA uptake level for the small size particles with which cell-adhesive proteins were incubated for a very short time (1 min) could be accounted for their inefficient binding with the cell-recognition molecules. The reason for low DNA uptake for the particles to which only E-cadherin-Fc was adsorbed in a time-dependent manner, is still not clear and might be related to the serum instability of the complex particles at the time of transgene delivery.
3.13. Transfection efficiency achieved with cell adhesive protein-embedded particles
Since transgene expression is the result of overcoming a number of barriers including entry into the cells, release from the particles and endosomes, and finally nuclear translocation [11], we checked whether accelerated DNA delivery owing to the improved DNA loading capacity and smaller sizes of fibronectin and E-cadherin-Fc-anchored carbonate apatite particles, contributed to the similar extent to final protein expression (Fig. 18). Quantitative luciferase expression demonstrated that particles generated by addition of fibronectin and fibronectin/E-cadherin-Fc after 5 min from the start of incubation of DNA-containing medium and incubation for an additional 25 min, enhanced 2 and 3-fold higher transgene expression than the control samples prepared by direct mixing with DNA. This is a significant achievement considering the high expression level already achieved with control samples [15]. The decline in luciferase expression for other samples is consistent with the low efficiency of DNA delivery as described before.
3.14. Role of protein kinase C on immobilized fibronectin and E-cad-Fc-mediated gene delivery
Since protein kinase C (PKC) in “inside-out” signaling cascade enhances integrin affinity towards ECM proteins promoting cell adhesion and spreading [23, 24] and up regulates endocytosis and recycling of E-cadherin [21], we have investigated the effect of Phorbol 12-myristate 13-acetate (PMA), a specific activator of PKC on trans-gene delivery mediated by particle-immobilized fibronectin and E-cadherin-Fc. As shown in Fig. 19, while only carbonate apatite particles are very inefficient in transfecting F9 cells even in presence of increasing doses of PMA (0 to 100 nM), fibronectin- or E-cad-Fc-embedded particles showed significant increment in luciferase gene expression ( 2 to 10 times) depending on PMA concentrations. Surprisingly, particles when associated with both of the “cell adhesive molecules” remarkably enhanced trans-gene expression resulting in almost 8, 14, 20 and 92-fold higher efficiency due to the presence of PMA at 1, 10, 50 and 100 nM concentrations, respectively. Immobilization of either fibronectin or E-cad-Fc on the particles also showed a dramatic increment in transgene expression, indicating clearly that both of the transmembrane proteins integrin and E-cadherin are up-regulated in response to PKC activation to promote efficient internalization of the bio-functional particles across the plasma membrane (data not shown here) and subsequent expression of the particle-associated DNA in cytoplasm [27] (Fig 19).
3.15. Transfection efficiency achieved in leukemia cells with cell adhesive protein-embedded particles
T cell expresses on its membrane α4β1 and α5β1 integrins which can bind fibronectin during lymphocyte adhesion and migration from vascular compartment to the injured tissues [22]. Moreover, αEβ7 integrin on some T cells can interact with epithelial E-cadherin for tissue-specific retention of lymphocytes [22]. We, therefore, aimed to functionalize the surface of DNA-associated nanocrystals with fibronectin and E-cadherin-Fc for transgene delivery through integrin-mediated endocytosis [22].
As shown in Fig. 20, luciferase expression in Jurkat cells was significantly low after delivery of luciferase gene-containing plasmid DNA with the help of carbonate apatite particles. A 3-fold enhancement in transgene expression was observed following delivery with fibronectin-embedded particles. Transgene expression could be further increased to the level (up to 6 times) equivalent to that of lipofection with the particles complexed with both fibronectin and E-cadherin-Fc. Since lymphocytes posses 2 different types of integrins (α4β1 and α5β1) being able to bind fibronectin [22], particles with electrostatically associated fibronectin could recognize any of the two receptors for efficient endocytosis in Jurkat cells leading to high transgene expression. However, particles with adsorbed E-cadherin-Fc reduced transfection efficiency below the level obtained with particles only, indicating that binding of E-cadherin-Fc probably neutralizes the positive charges of the particles as required for their subsequent interaction with anionic cell surface and additionally, E-cadherin-Fc on the particle surface might have low affinity interaction with the cell membrane integrin (αEβ7). On the other hand, the highest gene expression obtained with the particles complexed with both fibronectin and E-cadherin-Fc could be interpreted by the strong affinity of the composite particles towards the cell membrane due to the specific and synchronized recognition of the two different ligands on particle surface to their corresponding integrin receptors on plasma membrane, resulting in fast endocytosis of the particles along with DNA.
4. Conclusions
Stem cells possessing the inherent capability of transforming into many cell types, have been shown tremendous potential for cell-based therapies in regenerative medicine for neurological disease or injury [28], diabetes [29] and myocardial infarct [30]. The
Among the existing approaches for transgene delivery, viral systems suffer from their potential life-threatening effects of immunogenicity and carcinogenicity whereas non-viral ones, although safe, possess significant limitation in terms of efficacy [43]. Development of a safe as well as an efficient carrier is, therefore, an urgent requirement for effective implementation of the stem cells in regenerative medicine and the leukemia (or lymphocytes) in cancer treatment.
We have established a novel type of non-viral gene delivery systems based on pH-sensitive inorganic nanoparticles and revealed an innovative strategy for surface-functionalization of these biodegradable nanoparticles through their ionic interactions with “cell-adhesive molecules”. Moreover, the new approach has directly been applied for highly efficient delivery and expression of a trans-gene into “hard-to-transfect” embryonic stem cells- a success with tremendous future for stem-cell based therapeutic development. The involvement of E-cadherin and fibronectin in intercellular and extracellular interactions of cultured undifferentiated embryonic stem cells may exclude the possibility of stem cell differentiation following transfection with the new nano-apatite carriers associated with E-cad-Fc and fibronectin. More the same approach has successfully used to transfect the leukemia cells having potential application in cancer therapy.
Acknowledgments
This work has financially been supported by a research grant (Project ID 02-02-09-SF0013) of the Ministry of Science, Technology and Innovation (MOSTI), Malaysia.
References
- 1.
Kopatz I. Remy J. S. Behr J. P. 2004 A model for non-viral gene delivery: through syndecan adhesion molecules and powered by actin. 6 769 776 - 2.
Wu G. Y. Wu C. H. 1997 Receptor-mediated in vitro gene transformation by a soluble DNA carrier system. 262 4432 4439 - 3.
Cotton M. Längle-Rouault F. Kirlappos H. Wagner E. Mechtler K. Zenke M. Beug H. Birnstiel M. L. 1990 Transferrin-polycation-mediated introduction of DNA into human leukemic cells: stimulation by agents that affect the survival of transfected DNA or modulate transferrin receptor levels. 87 4033 4037 - 4.
Schaffer D. V. Lauffenburger D. A. 1998 Optimization of cell surface binding enhances efficiency and specificity of molecular conjugate gene delivery. 273 28004 28009 - 5.
Erbacher P. Bousser M. T. Raimond J. Monsigny M. Midoux P. Roche A. C. 1996 Gene transfer by DNA/glycosylated polylysine complexes into human blood monocyte-derived macrophages 7 721 729 - 6.
Hoganson D. K. Chandler L. A. Fleurbaaij G. A. Ying W. Black ME Doukas J. Pierce G. F. Baird A. Sosnowski BA 1998 Targeted delivery of DNA encoding cytotoxic proteins through high-affinity fibroblast growth factor receptors. 9 2565 2575 - 7.
Buschle M. Cotton M. Kirlappos H. Mechtler K. Schaffner G. Zauner W. Birnstiel M. L. 1995 Receptor-mediated gene transfer into human T lymphocytes via binding of DNA/CD3 antibody particles to the CD3 T cell receptor complex 6 753 761 - 8.
Erbacher P. Remy J. S. Behr J. P. 1999 Gene transfer with synthetic virus-like particles via the integrin-mediated endocytosis pathway. 6 138 145 - 9.
Wang S. Lee R. J. Cauchon G. Gorenstein D. G. Low P. S. 1995 Delivery of antisense oligodeoxyribonucleotides against the human epidermal growth factor receptor into cultured KB cells with liposomes conjugated to folate via polyethylene glycol. 92 3318 3322 - 10.
Parkes R. J. Hart S. L. 2000 Adhesion molecules and gene transfer. 44 135 152 - 11.
Chowdhury E. H. 2007 pH-sensitive nano-crystals of carbonate apatite for smart and cell-specific transgene delivery. 4 193 196 - 12.
Chowdhury E. H. Maruyama A. Kano A. Nagaoka M. Kotaka M. Hirose S. Kunou M. Akaike A. 2006 pH-sensing nano-crystals of carbonate apatite: effects on intracellular delivery and release of DNA for efficient expression into mammalian cells 376 87 94 - 13.
Chowdhury E. H. Kutsuzawa K. Akaike T. Designing Smart Nano-apatite Composites: The Emerging era of non-viral gene delivery. 9 301 316 - 14.
Kutsuzawa K. Maruyama K. Akiyama Y. Akaike T. Chowdhury E. H. 2008 Efficient transfection of mouse embryonic stem cells with cell-adhesive protein-embedded inorganic nanocarrier 372 122 124 - 15.
Kutsuzawa K. Chowdhury E. H. Nagaoka M. Maruyama K. Akiyama Y. Akaike T. 2006 Surface functionalization of inorganic nano-crystals with fibronectin and E-cadherin chimera synergistically accelerates trans-gene delivery into embryonic stem cells 350 514 520 - 16.
Shirayoshi Y. Okada T. S. Takeichi M. 1983 The calcium-dependent cell-cell adhesion system regulates inner cell mass formation and cell surface polarization in early mouse development 35 631 638 - 17.
Oka M. Tagoku K. Russell T. L. Nakano Y. Hamazaki T. Meyer E. M. Yokota T. Terada N. 2002 CD9 is associated with leukemia inhibitory factor-mediated maintenance of embryonic stem cells. 13 1274 1281 - 18.
Chowdhury E. H. Zohra F. T. Tada S. Kitamura C. Akaike T. 2004 Fibronectin in collaboration with Mg2+ enhances transgene expression by calcium phosphate coprecipitates. 335 162 164 - 19.
Chowdhury E. H. Nagaoka M. Ogiwara K. Zohra F. T. Kutsuzawa K. Tada S. Kitamura C. Akaike T. 2005 Integrin-supported fast rate intracellular delivery of plasmid DNA by extracellular matrix protein embedded calcium phosphate complexes. 44 12273 12278 - 20.
Overduin M. Harvey T. S. Bagby S. Tong K. I. Yau P. Takeichi M. Ikura M. 1995 Solution structure of the epithelial cadherin domain responsible for selective cell adhesion. 267 386 389 - 21.
Le Joseph T. L. Yap S. R. A. S. Stow J. L. 2002 Protein kinase C regulates endocytosis and recycling of E-cadherin. 283 C489 C499 - 22.
Kutsuzawa K. Maruyama K. Akiyama Y. Akaike T. Chowdhury E. H. 2008 The influence of the cell-adhesive proteins E-cadherin and fibronectin embedded in carbonate-apatite DNA carrier on transgene delivery and expression in a mouse embryonic stem cell line 29 370 376 - 23.
Kolanus W. Seed B. 1997 Integrins and inside-out signal transduction: converging signals from PKC and PIP3. 9 725 731 - 24.
Besson A. Wilson T. L. Yong V. W. 2002 The anchoring protein RACK1 links protein kinase Cepsilon to integrin beta chains. Requirements for adhesion and motility. 277 22073 22084 - 25.
Stephens L. E. Sonne J. E. Fitzgerald M. L. Damsky C. H. 1993 Targeted deletion of beta 1 integrins in F9 embryonal carcinoma cells affects morphological differentiation but not tissue-specific gene expression. 123 1607 1620 - 26.
Maeno Y. Moroi S. Nagashima H. Noda T. Shiozaki H. Monden M. Tsukita S. Nagafuchi A. 1999 alpha-catenin-deficient F9 cells differentiate into signet ring cells. 154 1323 1328 - 27.
Kutsuzawa K. Maruyama K. Akiyama Y. Akaike T. Chowdhury E. H. 2007 Protein kinase C activation enhances transfection efficacy of cell-adhesive protein-anchored carbonate apatite nanocrystals 37 116 117 - 28.
Webber D. J. Minger S. L. 2004 Therapeutic potential of stem cells in central nervous system regeneration. 5 714 719 - 29.
Hussain M. A. Theise N. D. 2004 Stem-cell therapy for diabetes mellitus. 364 203 205 - 30.
Mathur A. Martin J. F. 2004 Stem cells and repair of the heart. 364 183 192 - 31.
Duncan S. A. Navas MA Dufort D. Rossant J. Stoffel M. 1998 Regulation of a transcription factor network required for differentiation and metabolism. 281 692 695 - 32.
Li J. Ning G. Duncan S. A. 2000 Mammalian hepatocyte differentiation requires the transcription factor HNF-4alpha. 14 464 474 - 33.
Ishizaka S. Shiroi A. Kanda S. Yoshikawa M. Tsujinoue H. Kuriyama S. Hasuma T. Nakatani K. Takahashi K. 2002 Development of hepatocytes from ES cells after transfection with the HNF-3beta gene. 16 1444 1446 - 34.
Dohrmann C. Gruss P. Lemaire L. 2000 Pax genes and the differentiation of hormone-producing endocrine cells in the pancreas. 92 47 54 - 35.
Kim S. K. Hebrok M. 2001 Intercellular signals regulating pancreas development and function. 15 111 127 - 36.
Xian H. Q. Gottlieb D. I. 2001 Peering into early neurogenesis with embryonic stem cells. 24 685 686 - 37.
Adams S. W. Emerson S. G. 1998 Gene therapy for leukemia and lymphoma. 12 3 631 48 - 38.
Schakowski F. Buttgereit P. Mazur M. Märten A. Schöttker B. Gorschlüter M. Schmidt-Wolf I. G. 2004 Novel non-viral method for transfection of primary leukemia cells and cell lines 2 1 1 - 39.
Szeps M. Erickson S. Gruber A. Castro J. Einhorn S. Grandér D. 2003 Effects of interferon-alpha on cell cycle regulatory proteins in leukemic cells. 44 6 1019 25 - 40.
Finke S. Trojaneck B. Lefterova P. Csipai M. Wagner E. Kircheis R. Neubauer A. Huhn D. Wittig B. Schmidt-Wolf I. G. 1998 Increase of proliferation rate and enhancement of antitumor cytotoxicity of expanded human CD3+ CD56+ immunologic effector cells by receptor-mediated transfection with the interleukin-7 gene. 5 1 31 9 - 41.
Notter M. Willinger T. Erben U. Thiel E. 2001 Targeting of a B7-1 (CD80) immunoglobulin G fusion protein to acute myeloid leukemia blasts increases their costimulatory activity for autologous remission T cells. 97 10 3138 45 - 42.
Kato K. Cantwell MJ Sharma S. Kipps T. J. 1998 Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells. 101 5 1133 1141 - 43.
Chowdhury E. H. Akaike T. 2005 Bio-functional inorganic materials: an attractive branch of gene-based nano-medicine delivery for 21st century. 5 669 676